Nurse AMIE (Addressing Malignancies in Individuals Everyday)
2 other identifiers
interventional
344
1 country
8
Brief Summary
Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started May 2022
Longer than P75 for not_applicable cancer
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 3, 2022
CompletedStudy Start
First participant enrolled
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 10, 2026
March 1, 2026
4.8 years
January 27, 2022
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Survival of each participant will be monitored through the electronic medical records throughout the course of the study. After the study is completed, we will monitor survival using the National Death Index from the Centers for Disease Control and Prevention (CDC).
through study completion, an average of two years
Secondary Outcomes (11)
Change in Health-Related Quality of Life measured using the 36-Item Short Form Health Survey (SF-36)
baseline, month 6, month 12, month 18, month 24
Change in Physical Function measured using the Short Physical Performance Battery (SPPB)
baseline, month 6, month 12, month 18, month 24
Change in Symptoms measured using the Patient-Reported Outcomes Measurement Information System: The PROMIS ®-Preference (PROPr)
baseline, month 1, month 3, month 6, month 9, month 12, month 18, month 24
Cost-Effectiveness measured using a self-report survey of Healthcare Utilization
baseline
Cost-Effectiveness measured using a self-report survey of Healthcare Utilization
month1
- +6 more secondary outcomes
Study Arms (2)
Nurse AMIE Supportive Care Intervention
EXPERIMENTALParticipants in the intervention arm will receive the computer tablet with the Nurse AMIE program. Nurse AMIE will assess their symptoms daily and provide an intervention to help manage their symptoms.
Usual Care
ACTIVE COMPARATORParticipants in the usual care arm will receive a book with some supportive care educational materials and recommendations.
Interventions
Supportive Care Platform (behavioral interventions that are offered based on answers to daily symptom rating questions). Interventions offered include walking, balance, strength exercise, guided relaxation, mindfulness, CBT, DBT, soothing music.
Eligibility Criteria
You may qualify if:
- Patient receiving care for their cancer
- Age: 18+ years of age
- Has stage 3 or 4 cancer, or an unstaged cancer that is considered 'advanced' (greater than stage 2) by their treating oncologist
- Must be within six months of initiation of pharmacologic or radiation treatment, for curative or palliative purposes, from a medical or radiation oncologist
- Clinician-rated ECOG function of 0-3
- Lives in a county with RUCC code 4 - 9 and/or zip code with RUCA code 4-10
- Has access to personal device capable of receiving telephone calls for study facilitator check-ins
- Fluent in written and spoken English
- Sufficient vision/hearing to interact with the tablet and study staff
- Clinician-defined life expectancy of 6 months or more
You may not qualify if:
- Patients with medical or psychiatric conditions documented in the medical record (beyond cancer, its treatments, and its symptoms) that would impair our ability to test study hypotheses (e.g. psychotic disorders, dementia, inability to give informed consent, or follow study instructions).
- Patients who are participating in any other supportive care or behavioral intervention studies.
- Non-English speaking patients will be excluded, as they represent less than 2% of the population targeted.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Cancer Institute (NCI)collaborator
- West Virginia Universitycollaborator
- Mount Nittany Medical Centercollaborator
- Penn State Universitycollaborator
Study Sites (8)
UPMC-Butler
Butler, Pennsylvania, 16001, United States
UPMC - Greenville
Greenville, Pennsylvania, 16125, United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
UPMC - Indiana
Indiana, Pennsylvania, 15701, United States
UPMC - New Castle
New Castle, Pennsylvania, 16105, United States
UPMC - Northwest
Seneca, Pennsylvania, 16346, United States
Mount Nittany Medical Center
State College, Pennsylvania, 16803, United States
West Virginia University
Morgantown, West Virginia, 26506, United States
Related Publications (1)
Schmitz KH, Baker S, Werts-Pelter SJ, Doerksen S, Patterson CG, Ahmed M, Scalise R, Vincent A, Desroches C, Sobolewski M, Celebre R, Garrett S, Stout N, Calo WA, Fisher S, Schleicher E, Gordon B, Kumar P. Nurse AMIE randomized controlled trial to address symptom management among rural advanced Cancer patients: Addressing malignancies in everyday life. Contemp Clin Trials. 2025 Aug;155:108005. doi: 10.1016/j.cct.2025.108005. Epub 2025 Jul 10.
PMID: 40651555DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathryn Schmitz, PhD
University of Pittsburgh / UPMC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 27, 2022
First Posted
February 3, 2022
Study Start
May 3, 2022
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share